Pharmaceutical compositions designed for the relief of premenstrual syndrome are disclosed which comprise acetaminophen, caffeine, a diuretic ammonium salt and an antihistamine.
Pharmaceutical compositions and methods of using same comprising aspirin, sodium salicylate, salicylamide or acetaminophen, in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
A dry compressed ammonium nitrate tablet of solid ammonium nitrate and an auxilliary tabletting material is coated to enhance the paletability of the ammonium nitrate. Auxilliary tabletting substances include filling agents, binding agents, agents to stimulate disintegration of the tablets and lubricating agents. The ammonium nitrate tablets are particularly well suited for lowering the pH of urine.
The invention relates to a treatment for equine viral infections which includes potassium iodide, ammonium chloride and caffeine. A method of treating equine viral infections is also provided which involves administering the composition daily.
Disclosed are compositions comprising acetaminophen (APAP) and dimenhydrinate and methods for their use in analgesia. When acetaminophen and dimenhydrinate are within certain ratios, their pharmacological effects are superadditive.
A liquid composition for the relief of premenstrual and menstrual discomfort comprising, as active pharmaceutical agents, an effective amount of an analgesic, an antihistamine, and a diuretic, said active agents being dissolved in a liquid vehicle, said composition containing 5-25 percent by volume alcohol and being flavored with active flavoring elements selected from the group consisting of citrus, vanilla, and mint, said active flavoring ingredients being present in an amount sufficient to mask the unpleasant taste of the pharmaceutically active agents.